Algert Global LLC Keros Therapeutics, Inc. Transaction History
Algert Global LLC
- $4.77 Billion
- Q2 2025
A detailed history of Algert Global LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Algert Global LLC holds 55,570 shares of KROS stock, worth $865,780. This represents 0.02% of its overall portfolio holdings.
Number of Shares
55,570
Previous 27,480
102.22%
Holding current value
$865,780
Previous $280,000
165.0%
% of portfolio
0.02%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding KROS
# of Institutions
156Shares Held
38.6MCall Options Held
834KPut Options Held
969K-
Adar1 Capital Management, LLC Austin, TX5.39MShares$84 Million11.03% of portfolio
-
Madison Avenue Partners, LP New York, NY2.69MShares$41.9 Million3.85% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.63MShares$41 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.6MShares$40.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$39.2 Million0.0% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $401M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...